Obesity device firm EnteroMedics Inc. says it is on track to record the first commercial implants of its Maestro device in the next few months and is making progress towards gaining reimbursement for the neurostimulation system to control hunger cravings.
EnteroMedics Eyes First Commercial Maestro Implants For Obesity After Months Of Prep
The company says its training and facility certification efforts are on track to support commercial implants by June. The next challenge will be gaining broad-based reimbursement, as the first procedures are expected to be funded by self-pay or one-off local coverage.